As part of its biosimilar awareness initiative the Department of Health has published a review of all national and international clinical studies on biosimilars. According to the preface to the 55 page document, it will be used to “inform policy development” and ensure that the core messages of the Initiative remain relevant in a changing environment. ...
Biosimilar literature review will inform policy
6 Oct 2016